"Other changes from Makary include a shift away
Post# of 154563
(Total Views: 934)
Posted On: 04/19/2025 5:22:59 PM
"Other changes from Makary include a shift away from animal model requirements for investigational new drug (IND) applications for new monoclonal antibodies, with an increased focus on computational models and human cell lines and organoids."
https://www.fiercepharma.com/pharma/fda-block...committees
(6)
(0)